ICCC stock Statistics — Immucell CORP /De/ filings, insiders & smart money

Price and daily changeSign in

Earnings12 Nov 2026

52-week rangeSign inDay rangeSign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-07-31 · filed common shares: 9.08M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 2.73%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.21%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 44.50%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 38.00%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross marginTTM to Jun 26: 40.32%
Operating marginTTM to Jun 26: 12.60%
Net margin: —
EBITDA marginTTM to Jun 26: 20.48%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 2.57%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 1.77%

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

0.07

EPS (fwd)

Cash & equivalentsas of Jun 26: $8.86M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $12.44M
Debt / equityas of Jun 26: 39.67%
Current ratioas of Jun 26: 4.75
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 2.65
Operating cash flowTTM to Jun 26: $5.89M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: $4.21M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 3.38